TMA-2: Difference between revisions
From Pharmacopedia
More actions
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) Category taxonomy ship: retag Research Materials -> Research chemicals |
MDElliottMD (talk | contribs) home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean) |
||
| Line 21: | Line 21: | ||
| indications = | | indications = | ||
| dosing = | | dosing = | ||
<titration slug="erowid-dose-oral" author="erowid-claude" | |||
title="Oral dose ladder (Erowid, tentative)"> | |||
Erowid's dosage documentation for oral TMA-2<ref name="erowid-tma2-dose"> | |||
Erowid. TMA-2 Dosage. Erowid.org. | |||
https://www.erowid.org/chemicals/tma2/tma2_dose.shtml. | |||
Accessed 2026-05-25.</ref> reports the following tiers; Erowid explicitly | |||
notes that "little data exists about the dosage range in humans for TMA-2 | |||
and the following must be considered tentative": | |||
* '''Threshold:''' 7-12 mg | |||
* '''Light:''' 10-25 mg | |||
* '''Common:''' 20-50 mg | |||
* '''Strong:''' 40-60 mg | |||
* '''Heavy:''' 60+ mg | |||
Onset 30 to 90 minutes; duration 7 to 10 hours with up to 6 additional | |||
hours of aftereffects. Erowid's tentative qualifier should be reflected | |||
in any presentation of these figures. | |||
</titration> | |||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | | interactions = <pharmaInteractions/> | ||